United Kingdom (UK) - Healthcare, Regulatory and Reimbursement Landscape

This report presents valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.

The UK healthcare market is one of the most promising market globally, with universal health coverage and a strong focus on R&D in the field of genomics, artificial intelligence (AI), early-stage diagnostics, and big data. The UK pharmaceutical market increased from £13.77B in 2012 to £21.84B in 2019 at a Compound Annual Growth Rate (CAGR) of 6.8%. In terms of US Dollars, the market increased from $21.76B in 2012 to $29.42B in 2019 at a CAGR of 3.8%. It is forecast to reach about $35.52B in 2025. The key drivers contributing to the growth of the UK pharmaceutical market are universal healthcare coverage, the growing elderly population, increased access to healthcare services, high disease burden, and innovation in personalized medicines. However, the increased focus on generic drugs will be a barrier to the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the UK, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, GSK, AstraZeneca, and Merck
Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Roche Diagnostics, Siemens Healthineers, and Smith & Nephew
An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
An overview of the opportunities for and challenges to growth in the UK healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving the UK’s healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the UK’s healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

1. Table of Contents

1.1 List of Figures
1.2 List of Tables

2. Executive Summary

2.1 Executive Summary
2.2 Key Highlights - Facts about the UK Healthcare Market
2.3 Key Highlights: Healthcare Startups in the UK
2.4 Key Events: UK Healthcare Timeline, 2014-2021
2.5 Key Events: UK Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, UK, 2020

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, UK
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, UK
3.7 COVID-19 Epidemiology, UK
3.8 COVID-19 Impact and Developments in the Healthcare Market, UK
3.9 COVID-19 Clinical Trials Landscape, UK
3.10 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers

5.1 Drivers
5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, UK, 2020-2021
6.2 Deal Analysis: Medical Device Market, UK, 2020-2021

7. HealthTech Landscape

7.1 HealthTech Landscape, UK
7.2Adoption of Technology in Healthcare, UK
7.3 HealthTech Deals Landscape, UK
7.4 Key HealthTech Deals, UK
7.5Key Developments: Collaborations and Deals Toward Digital Health, UK
7.6Key Developments: National AI Strategy, UK
7.7 Regulatory Scenario Covering Use of Technology in Healthcare, UK
7.8 HealthTech Landscape: Benefits and Risks, UK

8. Market Access

8.1 Overview of Healthcare System, UK
8.2 Reimbursement Process, UK
8.3 Overview of Insurance Providers, UK
8.4 Healthcare Spending and Consumer Price Index, UK
8.5 Pricing Policies, UK
8.6 Regulatory Landscape, UK
8.6.1 Overview of Regulatory Agencies
8.6.2 Marketing Authorization for Pharmaceutical Products, UK
8.6.3 Marketing Authorization for Biosimilars, UK
8.6.4 Marketing Authorization for Medical Devices, UK
8.6.5 Intellectual Property Rights, Patent, UK
8.6.6 Intellectual Property Rights, Trademark, UK
8.6.7 Clinical Trial Regulation, UK
8.6.8 Pharmaceutical Clinical Trials Landscape, UK
8.6.9 Medical Devices Clinical Trials Landscape, UK
8.6.10 Pharmaceutical Advertisement Regulations, UK
8.6.11 Pharmacy Regulations, UK
8.6.12 Labeling and Packaging Regulations, UK
8.6.13 Post-Brexit Impact on UK Healthcare Regulatory Landscape, UK

9. Country Healthcare Landscape

9.1Healthcare Policy Highlights, UK
9.2 Healthcare Facilities, UK
9.3 Healthcare Parameters, UK
9.4 Life Expectancy and Immunization Rate, UK
9.5 Environmental Health, UK
9.6 Healthcare Personnel, UK
9.7 Disease Burden, UK
9.8 Healthcare Expenditure, UK
10 Trade Associations, UK

11 Trade Fairs, UK12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact Us
13.5 Disclaimer

List of Tables

Table 1: COVID-19 Indicators (Number of Cases), UK and Global, 2020-2021
Table 2: COVID-19 Drugs (by Manufacturer Database), UK and Global, 2020-2021
Table 3: COVID-19 Vaccines Authorized, UK, 2020-2021
Table 4: Medical Devices Market, UK, Major Segments ($B), 2020
Table 5: General Surgery Devices Market, UK, Revenue ($B) and Market Share (%) of Major Companies, 2019
Table 6: Orthopedic Devices Market, UK, Revenue ($B) and Market Share (%) of Major Companies, 2019
Table 7: Cardiovascular Devices Market, UK, Revenue ($B) and Market Share (%) of Major Companies, 2019
Table 8: Wound Care Management Market, UK, Revenue ($B) and Market Share (%) of Major Companies, 2020
Table 9: Anesthesia and Respiratory Devices Market, UK, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 10: Patent Fees, 2020, UK
Table 11: Trademark Fees, 2020, UK
Table 12: Clinical Trials Application Fees, 2020, UK
Table 13: Clinical Trials Application Fees for Medical Devices, 2020, UK
Table 14: Post-Brexit Impact on UK Healthcare Regulatory Landscape, UK, 2021
Table 15: Conferences and Trade Fairs, UK, 2021

List of Figures

Table 1: Pharmaceutical Market, UK, Revenue ($B), 2012-2020
Table 2: Medical Devices Market, UK, Revenue ($B), 2015-2020
Table 3: Healthcare Start-Ups in the UK, 2020
Table 4: Country Profile, UK, 2020
Table 5: Pharmaceutical Market, UK, Revenue ($B), 2012-2019
Table 6: Pharmaceutical Market, UK, Revenue Forecast ($B), 2020-2025
Table 7: Pharmaceutical Exports ($B), UK, 2012-2020
Table 8: Top Export Partners, UK, 2020
Table 9: Pharmaceutical Imports ($B), UK, 2012-2020
Table 10: Top Import Partners, UK, 2020
Table 11: Pharmaceutical Market, Supply Channel, UK, 2019
Table 12: Generic Drugs Usage (% Share by Volume), UK, 2011-2019
Table 13: Generic Drugs Usage (% Share by Value), UK, 2011-2019
Table 14: NHS Genomic Medicine Centers, UK, 2020
Table 15: Timeline of Cell and Gene Therapy Policies, UK, 2009-2021
Table 16: OTC Medicines Market, Major Categories ($M), UK, 2019
Table 17: OTC Medicines Market, Revenue ($B), UK, 2013-2020
Table 18: OTC Medicines Market, Major Distribution Channels ($M), UK, 2020
Table 19: Total Expenditure by Therapeutic Class ($B), UK, 2018
Table 20: Major Therapeutic Areas by Pharmaceutical Sales (Million Units), UK, 2016-2018
Table 21: COVID-19 (Number of Cases), UK, 2020-2021
Table 22: COVID-19 (Number of Deaths), UK, 2020-2021
Table 23: COVID-19-Related Travel Restrictions, UK, 2020-2021
Table 24: COVID-19 Fiscal Stimulus Timeline, UK, 2020-2021
Table 25: Vaccine Doses Administered per 1,000 People, UK, 2021
Table 26: Top COVID-19 In Vitro Diagnostic Products by Type (Number of Available Marketed Products), UK, 2020-2021
Table 27: Top COVID-19 IVD Products by Manufacturer (Number of Available Marketed Products), UK, 2020-2021
Table 28: Top COVID-19 IVD Products by Application (Number of Available Marketed Products), UK, 2020-2021
Table 29: Top COVID-19 IVD Products by Device Class (Number of Available Marketed Products), UK, 2020-2021
Table 30: COVID-19 Clinical Trials Count by Phase, UK, 2020-2021
Table 31: COVID-19 Clinical Trials Count by Trial Status, UK, 2020-2021
Table 32: Top Five COVID-19 Clinical Trials Sponsors by Count, UK, 2020-2021
Table 33: Pharmaceutical Market, Major Players, UK, 2020
Table 34: Medical Devices Market, UK, Revenue ($B), 2015-2020
Table 35: Medical Devices Market, UK, Revenue Forecast ($B), 2021-2025
Table 36: Medical Devices Market, Major Segments (%), UK, 2020
Table 37: General Surgery Devices Market, UK, Revenue ($B), 2017-2025
Table 38: General Surgery Devices Market, UK, Market Share of Major Players (%), 2019
Table 39: Orthopedic Devices Market, UK, Revenue ($B), 2017-2025
Table 40: Orthopedic Devices Market, UK, Market Share of Major Players (%), 2019
Table 41: Cardiovascular Devices Market, UK, Revenue ($B), 2017-2025
Table 42: Cardiovascular Devices Market, UK, Market Share of Major Players (%), 2019
Table 43: Wound Care Management Market, UK, Revenue ($B), 2017-2025
Table 44: Wound Care Management Market, UK, Market Share of Major Players (%), 2020
Table 45: Anesthesia and Respiratory Devices Market, UK, Revenue ($B), 2017-2025
Table 46: Anesthesia and Respiratory Devices Market, UK, Market Share of Major Players (%), 2020
Table 47: Diagnostic Market, UK, Revenue ($B), 2015-2020
Table 48: Diagnostic Market, UK, Revenue ($B), 2021-2025
Table 49: Medical Devices Market, Revenue ($B) of Major Companies, UK, 2019
Table 50: Deal Value and Deal Count, Pharmaceutical Market, UK, 2020-2021
Table 51: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, UK, 2020-2021
Table 52: Deal Value and Deal Count Sub-types, Pharmaceutical Market, UK, 2020-2021
Table 53: Top Therapy Areas by Deal Value ($B), Pharmaceutical Market, UK, 2020-2021
Table 54: Top Therapy Areas by Deal Count, Pharmaceutical Market, UK, 2020-2021
Table 55: M&A Deals by Quarter, Pharmaceutical Market, UK, 2020-2021 (by Value and by Number)
Table 56: VC Deals by Quarter, Pharmaceutical Market, UK, 2020-2021 (by Value and by Number)
Table 57: Deal Value and Deal Count, Medical Devices Market, UK, 2020-2021
Table 58: Deal Value and Deal Count, Quarterly, Medical Devices Market, UK, 2020-2021
Table 59: Deal Value and Deal Count Sub-types, Medical Devices Market, UK, 2020-2021
Table 60: Top Equipment Areas by Deal Value ($B), Medical Devices Market, UK, 2020-2021
Table 61: Top Equipment Areas by Deal Count, Medical Devices Market, UK, 2020-2021
Table 62: M&A Deals by Quarter, Medical Devices Market, UK, 2020-2021 (by Value and by Number)
Table 63: VC Deals by Quarter, Medical Devices Market, UK, 2020-2021 (by Value and by Number)
Table 64: Adoption of Technology in Healthcare, UK, 2020
Table 65: Deal Value ($B), HealthTech, UK, 2019-2020
Table 66: Deal Count (Number of Deals), HealthTech, UK, 2019-2020

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€1971EUR$1,995USD£1,641GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€3942EUR$3,990USD£3,281GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5914EUR$5,985USD£4,922GBP

Table of Contents

Related Topics

Related Reports

Behavioral Health Market Size, Share & Trends Analysis Report By Age Group, By Disorder (Substance Abuse Disorders, Alcohol Use Disorders, Eating Disorders, ADHD and Others), By Service, By Regional Outlook and Forecast, 2023 - 2030

Europe Behavioral Health Market Size, Share & Trends Analysis Report By Age Group, By Disorder (Substance Abuse Disorders, Alcohol Use Disorders, Eating Disorders, ADHD and Others), By Service, By Country and Growth Forecast, 2023 - 2030

Disease Management Apps Global Market Report 2024

Healthcare Revenue Cycle Management (Rcm) Software Market 2024-2028

Backend Revenue Cycle Management - Global Strategic Business Report